If you had asked me before 2pm today I would have guessed that Barry Bonds and Roger Clemens would have received around 50% of the vote. Not a lot given their baseball accomplishments, but a healthy vote for two players so thoroughly associated with PEDs. But they fell far short: Clemens received 37.6% of the vote, Bonds 36.2%.
I think there are two distinct groups of voters who voted no on these guys this year (1) the never ever voters; and (2) the not this year voters. The never ever voters will, obviously, never-ever vote for a PED user. They have drawn a bright moral line and will not consider these two no matter what happens. The not this year voters are voters who took Bonds’ and Clemens’ first year on the ballot as an opportunity to lodge a protest vote. I recall reading many columns by these sorts, all of whom said some version of “I may vote for them in the future, but I don’t know what to do with them now …” or something like it.
For Clemens and Bonds to make it in, that second camp has to be gigantic. And frankly, I can’t see it being such a large group of people that it will allow them to jump up by nearly 40% in the vote be it next year or ten years from now. Given how low their vote totals are the never ever camp has to comprise more than 25% of the electorate, and it only takes one more than 25% of the electorate to block a player.
Maybe attrition changes this, but I have my doubts. It’s fashionable to say that the “old man” voters oppose Bonds and Clemens and then assume that, over time, those voters will die off while younger, more progressive voters fill the BBWAA’s ranks. But I don’t necessarily buy that. There are a lot of “old man” voters who don’t think PEDs are a mortal sin. Maybe because they remember segregation and its after effects, greenies, cocaine and all manner of other bad things and know damn well that there are worse things in baseball than someone taking steroids. Meanwhile, there are a lot of Hall of Fame voters south of 50 who are among the most virulent anti-PED guys as you’ll find anywhere. Even if you’re counting on attrition, it’s going to take longer than the 14 years Bonds and Clemens have on the ballot to make a difference.
No, the only chance those two have to make the Hall of Fame is for some sort of fundamental change in the process to happen. For the BBWAA to alter the composition of its electorate, for MLB and the Hall of Fame to come out with some sort of formal diktat that PED use should not be considered in Hall of Fame voting or for the BBWAA to have the Hall of Fame vote taken away from it altogether.
I don’t see any of those three things happening. And for that reason, I don’t see Barry Bonds or Roger Clemens getting into the Hall of Fame without a ticket any time soon.
Jordan Zimmermann signed with the Tigers on Sunday for five years, $110 million. David Price signed with the Red Sox on Monday for seven years, $217 million.
Two big dominos have fallen in this loaded free agent market for starting pitchers, and another big one is about to go …
FOX Sports’ Ken Rosenthal says a deal for Zack Greinke “could come soon” and it’s currently “Dodgers vs. Giants” at the top of the bidding ladder.
ESPN’s Jerry Crasnick confirms that both the Dodgers and Giants are looking for an answer from Greinke, adding that the 32-year-old right-hander seeks a five- or six-year deal with a greater average annual value (AAV) than what Price just secured from Boston. That number would be $31 million, so we’re talking something close to $32 million through 2020-2021.
Greinke opted out of the remaining three years and $71 million contract with Los Angeles in October after posting a 1.66 ERA and 0.84 WHIP across 222 2/3 regular-season innings in 2015. He finished second to the Cubs’ Jake Arrieta in the National League Cy Young Award balloting.
Multiple reports circulated in the past week that the Red Sox would need to unload the money truck in order to sign David Price. Well, the truck just got unloaded: Pete Abraham of the Boston Globe reports that the Red Sox have signed David Price to a seven-year, $217 million contract.
This is, by far, the largest free agent contract the Red Sox have ever given a pitcher. It beats Max Scherzer‘s seven-year, $210 million deal signed last offseason as the largest ever free agent pitcher contract. Clayton Kershaw‘s contract extension with the Dodgers was for $215 million.
Price went 82-47 with a 3.18 ERA pitching in the AL East while with the Tampa Bay Rays. After being traded to the Tigers just before the 2014 trade deadline he went 13-8 with a 2.90 ERA in 32 starts. He returned to the AL East with the Blue Jays this year, going 9-1 with a 2.30 ERA in 11 starts. He also pitched in the playoffs for the Jays starting three times in four overall appearances.
The Red Sox were in dire need of pitching and they were said to be gunning for Price to fill that need. Target: acquired.
MLB and the MLBPA just released the annual public report from the Joint Drug Prevention and Treatment Program’s Independent Program Administrator. It’s the annual report, mandated by the JDA, which says how many positive drug tests there were, what the drugs were, etc.
The notable numbers, which cover the period starting when the 2014 World Series ended until the 2015 World Series ended:
- Total number of tests administered: 8,158. 6,536 of them were urine tests, 1,622 of them were blood tests for HGH;
- 10 tests resulted in positives which led to discipline: 7 for PEDs, 2 for stimulants, one for DHEA;
- The previous year there were 7,929 total tests with 12 which resulted in discipline;
- There were the same number of Therapeutic Use Exemptions granted this year as last: 113. All but two were for attention deficit disorder. One was for gynecomastia, which is the swelling of the breast tissue in men due to a hormone imbalance, one was for a stress fracture in someone’s elbow.
A use exemption line item which had appeared on the list for the previous several years — hypogonadism — was not there, so congratulations to the anonymous player who was either cured or who retired.
As we always note, the number of players who got exemptions for ADD drugs is a bit higher than the occurrence of ADD in the population at large and, once you eliminate kids from ADHD occurrences, it’s likely considerably higher. But that’s none of my business.
With a week remaining in their exclusive negotiating window to sign Byung-ho Park the Twins have agreed to a deal with the Korean slugger. Ken Rosenthal of FOXSports.com reports that it’s a four-year, $12 million contract, on top of which the Twins will pay Park’s old team a $12.85 million posting fee for those negotiating rights.
Four years and a total commitment of $24.85 million is certainly a sizable investment, but it’s significantly less than most projections had the Twins spending to get Park under contract.
Last offseason the Pirates bid $5 million to negotiate with Korean shortstop Jung Ho Kang and then signed him to a four-year, $11 million deal. His success in MLB raised the level of interest in Park, who posted similarly spectacular numbers in Korean, but in the end the price tag wasn’t significantly higher. Based on reports from Korea, it sounds like the Twins low-balled him in negotiations and Park basically just accepted it because he wants to play in MLB.
Three weeks ago I wrote a lengthy breakdown of how Park could fit into the Twins’ plans when they secured the high bid, but the short version is that he’ll slot into the lineup as the starting designated hitter and look to prove that his exceptional production in Korean can carry over to MLB. Park hit .343 with 53 homers, 146 RBIs, and a 1.150 OPS in 140 games for Nexen this past season and has topped a 1.000 OPS in each of the past three years.